Gritstone bio, Inc. (GRTS) Financials
Stock symbol GRTS is outdated, potentially delisted? Maybe it is available on other exchange?
GRTS Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2024 | 142.5 million | 120.4 million |
| March 31, 2024 | 137.2 million | 123.2 million |
| Dec. 31, 2023 | 177.8 million | 125.9 million |
| Sept. 30, 2023 | 187.2 million | 113.2 million |
GRTS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2024 | -26.8 million | 3.5 million |
| March 31, 2024 | -33.7 million | 3.2 million |
| Dec. 31, 2023 | -34.6 million | 2.8 million |
| Sept. 30, 2023 | -32.2 million | 3.0 million |
GRTS Net Income
No data available :(
GRTS Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2024 | 57.0 million | 95.3 million | 62.0 million |
| March 31, 2024 | 47.6 million | 96.5 million | 63.0 million |
| Dec. 31, 2023 | 81.6 million | 97.9 million | 64.6 million |
| Sept. 30, 2023 | 83.9 million | 89.3 million | 65.4 million |
GRTS Shares Outstanding
GRTS Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2024 | 32000 | 20.8 million | 6.1 million | -1.6 million |
| March 31, 2024 | 143000 | 33.0 million | 6.8 million | -1.7 million |
| Dec. 31, 2023 | 191000 | 32.9 million | 6.0 million | -1.9 million |
| Sept. 30, 2023 | 1.1 million | 32.8 million | 7.4 million | - |
GRTS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2024 | 57000 | 1.6 million |
| March 31, 2024 | 49000 | 1.7 million |
| Dec. 31, 2023 | 29000 | 1.9 million |
| Sept. 30, 2023 | 1.6 million | 2.0 million |
GRTS Revenue by Segment
Graph available only for paid members. Upgrade to see it.
GRTS
Price: $0.03
52 week price:
Earnings Per Share: -1.09 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 427892
Market Capitalization: 3.8 million